Ipca Labs approves acquisition of 26.5% stake in Lyka Labs - Livemint
Shares of Ipca Labs were trading 1% lower at ?2037.80 while Lyka were locked in 5% upper circuit as compared to a 0.5% gain in Nifty pharma index.
The board of Ipca Labs has approved the acquisition of 26.574% of the paid-up share capital of Lyka Labs Limited and entering into a joint management control agreement with the promoters of Lyka Labs… [+1606 chars]
Read More
Other Stories in Business
- Gulf War veteran executed for 1998 quadruple murder despite claims of mental illness
- Guardant Health (GH) Reports Strong Q1 2025 Revenue Growth
- Connecting Asia's startup ecosystem
- Connecting Asia's startup ecosystem
- From a Joke That Went Too Far to Radical Ideology – How Did the Memecoin Paradigm Change
- From a Joke That Went Too Far to Radical Ideology – How Did the Memecoin Paradigm Change
- L3Harris Technologies Stock: A Steady Course In A Changing World (NYSE:LHX)
- L3Harris Technologies Stock: A Steady Course In A Changing World (NYSE:LHX)
- Business First Bancshares, Inc. (BFST) Q1 2025 Earnings Call Transcript
